Complete Health, a physician-centric, primary care group, announced today it is partnering with Collaborative Health Systems (CHS),…
Category: News
The Alliance for Physician Certification and Advancement Teams Up to Ensure Proper Use of Ultrasound by Physical Therapists
Inteleos™ today announced that its council, The Alliance for Physician Certifications and Advancement™ (APCA™), has partnered with The American Physical Therapy…
Alkermes to Take Part in the Goldman Sachs Annual Global Healthcare Conference
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the Goldman…
Qazi Cosmetic Clinic Announces Pain-Free MicroLipo™ to Banish Double Chins and Saggy Skin Just in Time for the End of the Pandemic
Spending the past year on Zoom, with its magical retouching and soft-light camera features, has been…
Lung Cancer Research Foundation and EGFR Resisters Announce Partnership
The Lung Cancer Research Foundation (LCRF) is excited to announce a partnership with leading lung cancer…
Choice Health at Home Announces Multiple Acquisitions in Texas and Oklahoma
Choice Health at Home, LLC (“Choice”) announced today the acquisition of multiple home health and hospice…
Cantel Medical LLC Announces Offer to Purchase Relating to Outstanding Convertible Senior Notes
Cantel Medical LLC, formerly known as Cantel Medical Corp. (the “Company,” “Cantel,” “we” or “our”), today…
Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Barth Syndrome
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of…
Statement on Physician-Led Care and Physician Assistant Title Change and non-Physician Clinician use of the title “Doctor”
The American Osteopathic Association calls for truth in advertising, intellectual honesty, and transparency with the use…
Ibere Pharmaceuticals Receives Expected NYSE Notice Regarding Delayed Quarterly Report
Ibere Pharmaceuticals (NYSE: IBER) (the “Company”) today announced that it received a notice on May 25, 2021 from the…